<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Alpha Neuron Business Blog &#187; Venture Capital</title>
	<atom:link href="http://www.alphaneuron.com/blog/category/venture-capital/feed" rel="self" type="application/rss+xml" />
	<link>http://www.alphaneuron.com/blog</link>
	<description>Make Better Business Decisions</description>
	<lastBuildDate>Sun, 20 Sep 2009 14:26:53 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Forma Therapeutics Manages Funding Deal From Novartis</title>
		<link>http://www.alphaneuron.com/blog/forma-therapeutics-manages-funding-deal-from-novartis.html</link>
		<comments>http://www.alphaneuron.com/blog/forma-therapeutics-manages-funding-deal-from-novartis.html#comments</comments>
		<pubDate>Tue, 13 Jan 2009 11:24:43 +0000</pubDate>
		<dc:creator>shankar_avsb</dc:creator>
				<category><![CDATA[Business Strategy]]></category>
		<category><![CDATA[Financial Management]]></category>
		<category><![CDATA[M&#038;A]]></category>
		<category><![CDATA[Pharma_Biotech]]></category>
		<category><![CDATA[R&#038;D]]></category>
		<category><![CDATA[Venture Capital]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech funding]]></category>
		<category><![CDATA[biotech stock research]]></category>
		<category><![CDATA[pharma stock research]]></category>

		<guid isPermaLink="false">http://www.alphaneuron.com/blog/forma-therapeutics-manages-funding-deal-from-novartis.html</guid>
		<description><![CDATA[
Forma Therapeutics  has revealed that it has done a deal with Novartis, agreeing to use its chemistry platform to develop inhibitors for an undisclosed protein-protein interaction target in oncology.
The license and option pact is worth up to $200 million in upfront fees and milestones.
Forma only recently dropped its stealth approach to announce that it had [...]]]></description>
		<wfw:commentRss>http://www.alphaneuron.com/blog/forma-therapeutics-manages-funding-deal-from-novartis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Avalon Pharma Cuts Staff as It Scrambles to Raise Cash</title>
		<link>http://www.alphaneuron.com/blog/avalon-pharma-cuts-staff-as-it-scrambles-to-raise-cash.html</link>
		<comments>http://www.alphaneuron.com/blog/avalon-pharma-cuts-staff-as-it-scrambles-to-raise-cash.html#comments</comments>
		<pubDate>Thu, 14 Aug 2008 20:17:44 +0000</pubDate>
		<dc:creator>shankar_avsb</dc:creator>
				<category><![CDATA[Business Plan]]></category>
		<category><![CDATA[Business Strategy]]></category>
		<category><![CDATA[Financial Management]]></category>
		<category><![CDATA[M&#038;A]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[People &#038; Teams]]></category>
		<category><![CDATA[Pharma_Biotech]]></category>
		<category><![CDATA[R&#038;D]]></category>
		<category><![CDATA[Venture Capital]]></category>
		<category><![CDATA[biotech business]]></category>
		<category><![CDATA[biotech funding]]></category>
		<category><![CDATA[cashflow management]]></category>
		<category><![CDATA[cashflow problems]]></category>

		<guid isPermaLink="false">http://www.alphaneuron.com/avalon-pharma-cuts-staff-as-it-scrambles-to-raise-cash/</guid>
		<description><![CDATA[Options for Avalon’s Board
Best Option: Raise debt capital, pledging whatever assets it can, and use that for two purposes:
(a) do the biotech drug development with a strict performance based incremental investment
(b) start a service based revenue stream that can generate some operating cash.
Avalon Board and CXOs have to figure out what services they can offer [...]]]></description>
		<wfw:commentRss>http://www.alphaneuron.com/blog/avalon-pharma-cuts-staff-as-it-scrambles-to-raise-cash.html/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Milestone Based Payments &#8211; Its The Best Way</title>
		<link>http://www.alphaneuron.com/blog/milestone-based-payments-its-the-best-way.html</link>
		<comments>http://www.alphaneuron.com/blog/milestone-based-payments-its-the-best-way.html#comments</comments>
		<pubDate>Thu, 05 Jun 2008 14:26:00 +0000</pubDate>
		<dc:creator>shankar_avsb</dc:creator>
				<category><![CDATA[Business Strategy]]></category>
		<category><![CDATA[Contracts &#038; Legal]]></category>
		<category><![CDATA[Financial Management]]></category>
		<category><![CDATA[M&#038;A]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[People &#038; Teams]]></category>
		<category><![CDATA[Personal Finance]]></category>
		<category><![CDATA[Venture Capital]]></category>

		<guid isPermaLink="false">http://www.alphaneuron.com/milestone-based-payments-its-the-best-way/</guid>
		<description><![CDATA[How many times have you made payments/investments for promised results which never happened?
Well, I have made that mistake a few times over the last 2 decades, and each time, the learning has improved.  And the success rate of deals has also improved.
There are professionals of all types &#8211; who will ask for upfront money &#8211; [...]]]></description>
		<wfw:commentRss>http://www.alphaneuron.com/blog/milestone-based-payments-its-the-best-way.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Capital Raising Secrets for Start-ups &amp; Early Stage Companies</title>
		<link>http://www.alphaneuron.com/blog/capital-raising-secrets-for-start-ups-early-stage-companies.html</link>
		<comments>http://www.alphaneuron.com/blog/capital-raising-secrets-for-start-ups-early-stage-companies.html#comments</comments>
		<pubDate>Tue, 04 Mar 2008 14:19:01 +0000</pubDate>
		<dc:creator>shankar_avsb</dc:creator>
				<category><![CDATA[Business Plan]]></category>
		<category><![CDATA[Contracts &#038; Legal]]></category>
		<category><![CDATA[Financial Management]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Startup]]></category>
		<category><![CDATA[Venture Capital]]></category>
		<category><![CDATA[Capital Raising]]></category>
		<category><![CDATA[Early Stage Companies]]></category>
		<category><![CDATA[Regulation-D]]></category>
		<category><![CDATA[SEC]]></category>
		<category><![CDATA[Share Pricing]]></category>
		<category><![CDATA[Start-ups]]></category>

		<guid isPermaLink="false">http://www.alphaneuron.com/capital-raising-secrets-for-start-ups-early-stage-companies/</guid>
		<description><![CDATA[If you are leading any type of business, then you will be making decisions about capital structure &#8211; how much equity, how much debt &#8211; what sources, when, etc? It does not matter whether you are a start-up or a Fortune 100 company. In fact, capital raising and venture funding is one of the most [...]]]></description>
		<wfw:commentRss>http://www.alphaneuron.com/blog/capital-raising-secrets-for-start-ups-early-stage-companies.html/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Investment Term Sheet Sample</title>
		<link>http://www.alphaneuron.com/blog/investment-term-sheet-sample.html</link>
		<comments>http://www.alphaneuron.com/blog/investment-term-sheet-sample.html#comments</comments>
		<pubDate>Thu, 24 Jan 2008 19:05:31 +0000</pubDate>
		<dc:creator>shankar_avsb</dc:creator>
				<category><![CDATA[Business Plan]]></category>
		<category><![CDATA[Contracts &#038; Legal]]></category>
		<category><![CDATA[Startup]]></category>
		<category><![CDATA[Venture Capital]]></category>
		<category><![CDATA[Investment Term Sheet]]></category>
		<category><![CDATA[Sample Contract]]></category>
		<category><![CDATA[Stock Issue]]></category>

		<guid isPermaLink="false">http://www.alphaneuron.com/blog/investment-term-sheet-sample/</guid>
		<description><![CDATA[Many people have asked us in the last few months about documents related to the venture funding process. The Investment Term Sheet is a key document that starts serious final round discussions for funding with a serious potential investor. It is like an engagement before marriage. Here is a sample Investment Term Sheet.
INVESTMENT TERM SHEET
CONFIDENTIAL
Issuer: [...]]]></description>
		<wfw:commentRss>http://www.alphaneuron.com/blog/investment-term-sheet-sample.html/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
